Cat. No.: X24-08-YM249
Microtubule/Tubulin inhibitor, VCP-Eribulin, Purity ≥98%
Synonym: 2130869-17-7; HY-128871; CS-0101613; [4-[[(2S)-2-[[(2S)-2-Amino-3-methylbutanoyl]amino]-5-(carbamoylamino)pentanoyl]amino]phenyl]methyl N-[(2S)-2-hydroxy-3-[(1S,3S,6S,9S,12S,14R,16R,18S,20R,21R,22S,26R,29S,31R,32S,33R,35R,36S)-21-methoxy-14-methyl-8,15-dimethylidene-24-oxo-2,19,30,34,37,39,40,41-octaoxanonacyclo[24.9.2.13,32.13,33.16,9.112,16.018,22.029,36.031,35]hentetracontan-20-yl]propyl]carbamate
- CAS Number: 2130869-17-7
- Compound CID: 138911393
Product Size
1 mg; 2 mg; 5 mg; 10 mg
Properties
Description
VCP-Eribulin is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting microtubule/tubulin.
Molecular Formula
C59H86N6O16
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
VCP-Eribulin is a cytoskeletal signaling inhibitor that can be used for its ability to enhance targeted delivery to cancer cells.
Related Products
- Microtubule/Tubulin inhibitor, Monomethyl auristatin E, Purity ≥98%
- Microtubule/Tubulin inhibitor, ABT-751, Purity ≥98%
- Microtubule/Tubulin inhibitor, Albendazole, Purity ≥98%
- Microtubule/Tubulin inhibitor, Chloroxine, Purity ≥98%
- Microtubule/Tubulin inhibitor, CYT997, Purity ≥98%
- Microtubule/Tubulin inhibitor, Epothilone A, Purity ≥98%
